Global Blood Therapeutics Price Prediction
| GBTDelisted Stock | USD 68.49 0.00 0.00% |
Oversold Vs Overbought
76
Oversold | Overbought |
Global Blood Therapeutics stock price prediction is an act of determining the future value of Global Blood shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Global Blood's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Global Blood and does not consider all of the tangible or intangible factors available from Global Blood's fundamental data. We analyze noise-free headlines and recent hype associated with Global Blood Therapeutics, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Global Blood based on different types of headlines from major news networks to social media. The Global stock price prediction module provides an analysis of price elasticity to changes in media outlook on Global Blood over a specific investment horizon. Using Global Blood hype-based prediction, you can estimate the value of Global Blood Therapeutics from the perspective of Global Blood response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Global Blood. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Global Blood to buy its stock at a price that has no basis in reality. In that case, they are not buying Global because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Global Blood after-hype prediction price | USD 68.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Global |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Global Blood's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Global Blood After-Hype Price Prediction Density Analysis
As far as predicting the price of Global Blood at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Global Blood or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Global Blood, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Global Blood Estimiated After-Hype Price Volatility
In the context of predicting Global Blood's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Global Blood's historical news coverage. Global Blood's after-hype downside and upside margins for the prediction period are 68.49 and 68.49, respectively. We have considered Global Blood's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Global Blood is very steady at this time. Analysis and calculation of next after-hype price of Global Blood Therapeutics is based on 3 months time horizon.
Global Blood Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Global Blood is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Global Blood backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Global Blood, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
68.49 | 68.49 | 0.00 |
|
Global Blood Hype Timeline
On the 23rd of April Global Blood Therapeutics is traded for 68.49. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Global is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Global Blood is about 0.0%, with the expected price after the next announcement by competition of 68.49. About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.04. Global Blood Therapeutics had not issued any dividends in recent years. Considering the 90-day investment horizon the next forecasted press release will be in a few days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.Global Blood Related Hype Analysis
Having access to credible news sources related to Global Blood's direct competition is more important than ever and may enhance your ability to predict Global Blood's future price movements. Getting to know how Global Blood's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Global Blood may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RCKY | Rocky Brands | 1.15 | 9 per month | 4.10 | 0 | 6.10 | (4.76) | 22.46 | |
| HAS | Hasbro Inc | (0.66) | 8 per month | 0.92 | 0.12 | 3.31 | (2.06) | 7.24 | |
| PRKS | United Parks Resorts | (2.76) | 10 per month | 1.91 | 0.0007 | 3.54 | (3.06) | 12.63 | |
| ASO | Academy Sports OutdoorsInc | 0.61 | 11 per month | 0.00 | (0.09) | 3.16 | (3.98) | 14.10 | |
| PLTK | Playtika Holding Corp | (0.27) | 10 per month | 0.00 | (0.06) | 3.16 | (3.52) | 19.98 | |
| LTH | Life Time Group | (0.11) | 12 per month | 2.30 | 0 | 4.01 | (3.97) | 15.01 | |
| DOOO | BRP Inc | (0.61) | 10 per month | 2.09 | (0.01) | 3.44 | (3.55) | 11.09 |
Global Blood Additional Predictive Modules
Most predictive techniques to examine Global price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Global using various technical indicators. When you analyze Global charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Global Blood Predictive Indicators
The successful prediction of Global Blood stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Global Blood Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Global Blood based on analysis of Global Blood hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Global Blood's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Global Blood's related companies. Story Coverage note for Global Blood
The number of cover stories for Global Blood depends on current market conditions and Global Blood's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Global Blood is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Global Blood's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Global Blood Short Properties
Global Blood's future price predictability will typically decrease when Global Blood's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Global Blood Therapeutics often depends not only on the future outlook of the potential Global Blood's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Global Blood's indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 14.18% | |
| Short Percent Of Float | 14.58% | |
| Float Shares | 52.61M | |
| Shares Short Prior Month | 10.65M | |
| Average Daily Volume Last 10 Day | 2.06M | |
| Average Daily Volume In Three Month | 3.85M | |
| Date Short Interest | 15th of July 2022 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Global Blood Therapeutics information on this page should be used as a complementary analysis to other Global Blood's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Global Stock
If you are still planning to invest in Global Blood Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Global Blood's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |